Among breast cancer patients in the United States, Black women are more likely to start treatment later and to have a longer treatment period than white women, new research shows.
For the study, researchers at the University of North Carolina at Chapel Hill analyzed data from more than 2,800 patients (about equal numbers of Black women and White women) with stage 1 to 3 breast cancer in the Carolina Breast Cancer Study.
The overall median time to start of treatment was 34 days, but Black women were more likely than White women to have a delayed start to treatment (13% versus 8%, respectively) and a long treatment duration (30% versus 21%, respectively).
Nearly one-third (32%) of younger Black women were in the highest quartile of treatment duration, compared with just over 22% of younger White women. Meanwhile, 28% of older Black women had prolonged treatment duration compared with 20% of